The S&P 500 Biotech Index has nearly tripled in the past three years. The index had stalled and moved sideways for much of the past spring, leading some to wonder whether the rally was spent. Several factors have been fueling the biotech rally of the past three years. For one thing, the U.S. Food and Drug Administration has been pushing […]
Via Dana Lyons’ Tumblr,We’ve used much of the space here in the past several weeks pointing out the deteriorating breadth conditions in the U.S. equity market. The trend has been so profound it has now reached the point where it could potentially shift from one of short or intermediate-term relevance to something that might impact the longer-term cyclical bull market. […]
Ishares Nasdaq Biotechnology Index (IBB) has been on a tear in the last year, outperforming the NASDAQ and S&P 500 by multiples greater than 3x and 6x, respectively. This rapid appreciation has spurted chatter of a bubble forming in the biotech sector. Even US leaders have expressed a difference of opinion. Yellen, for example, stated back in July 2014 that the biotech industry […]
Back in 2000 I was a biomedical engineering student at Virginia (who happens to be in the College baseball World Series, go Hoos!). I was in love with genetics and all things biotech, but also spent plenty of time reading annual reports and buying and selling (often shorting) stocks. One of the classes I enrolled in outside of engineering (if you are […]
The New York Stock Exchange (NYSE) has today announced the launch of a bitcoin price index (NYXBT).NYXBT will represent the daily US dollar value of one bitcoin at 4pm (BST) and will be published on the NYSE Global Index Feed (GIF).For a limited period it will also be viewable on the NYSE’s website.Thomas Farley, NYSE group president, said in a […]
zerohedge.com / by Tyler Durden on 05/07/2015 12:51Three days ago, when looking at the unprecedented, record outflows from US equities (coupled with continued inflow into bond funds into what BofA’s Hans Mikkelsen would likely dub the Great Antirotation) we asked a simple question: “who is buying… no really“.Then yesterday, the spoofing algos were briefly spooked when Yellen, for the second […]
In case you thought paying $7 to $10 to trade a stock in the US was bad, it costs $65 in Australia. So now that its zero-fee stock trading app is thriving stateside with hundreds of thousands of users, Robinhood is planning to go international, starting in Australia. A $50 million Series B cash infusion from NEA will fuel that expansion, […]
Khailee Ng (left) and Dinesh Bhatia (right), co-founder and CEO of TradeHeroIn the past, Tech in Asia has referred to TradeHero as one of the best startups in Singapore. The firm offers an app that lets users trade virtual money based on real-world stock market data. Essentially, it’s a game, but with interesting implications.On TradeHero, users who are less familiar […]
Atlas Venture went through a corporate divorce last fall, as its tech partners and biotech partners went their separate ways. Now the biotech team has moved on, and re-loaded with twice the money they’ve had in the past.The Cambridge, Mass.-based firm, founded back in 1980, is announcing today it has closed on a new $280 million fund, its tenth, to […]
Momentum Stocks: Caution Ahead (Part 4 of 6)(Continued from Part 3)Another case in point is biotech.Biotech is another obvious example of the momentum trade. It is a high “beta” or risky industry that has been a strong relative performer for many years. Through the close of the week ended March 20, the Nasdaq Biotech Index had surged 20% year-to-date. The following […]
